Aspercreme Lidocaine XL Patch

Manufacturer
Lead Chemical Co., Ltd.
Effective date
2026-05-29
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
daily-update
Hydrated at
2026-07-15 00:32:58

Label at a glance#

ProductAspercreme Lidocaine XL
Active ingredientLIDOCAINE
Label structure7 sections

Dosage and administration

•   adults and children 12 years of age and older: • clean and dry affected area • remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle • carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area • once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affect...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Topical anesthetic

Use

INDICATIONS & USAGE SECTION

for the temporary relief of pain

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on wounds or on irritated or damaged skin
  • more than 1 patch on your body at a time or with other topical analgesics at the same time
  • with a heating pad

When using this product

OTC - WHEN USING SECTION

  • use only as directed
  • do not bandage tightly
  • avoid contact with eyes and mucous membranes
  • do not expose the area to local heat or to direct sunlight

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days
  • redness is present or excessive skin irritation occurs
  • you experience severe burning pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children and pets.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Used patches may still contain the drug product that can produce serious adverse effects if ingested by children or pets. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

•   adults and children 12 years of age and older:

  • clean and dry affected area
  • remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
  • carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
  • once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
  • apply to the affected area not more than 3 to 4 times daily
  • wash hands after applying or removing patch. Throw away the patch after folding sticky ends together.

•   children under 12 years of age: ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LIDOCAINE
#1
BRAND*

 
MAX STRENGTH †
Aspercreme®
WITH 4% LIDOCAINE
PAIN RELIEVING PATCH
 
ODOR FREE
XL PATCH
71% LARGER**
NUMBS AWAY PAIN
 
Fast Acting
Targets Nerves
Flexible Fabri
c
 
Contains 1 Patch
4-3/4” X 7-7/8” (12 cm x 20 cm)
 
Pain Relieving Ointment on a
Breathable Adhesive Pad

*Among OTC topical analgesics
†Among OTC topical analgesics for the
indicated Use(s)
**Than 10 cm X 14 cm Aspercreme® patches.

 
Distributed by: Chattem, Inc.,
P.O. Box 2219, Chattanooga, TN 37409-0219
©2025     www.aspercreme.com
Made in Japan

image-01
image-01

Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62168-058562168-0585-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
52024-01-02full-release2026-06-01 00:07:35

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aspercreme Lidocaine XLLIDOCAINELead Chemical Co., Ltd.b1077b76-7ae7-4b1b-a972-c1b10e9671f92026-05-29WarningsExact identifier
ndc (package): 62168-0585-2
ndc (product): 62168-0585
ndc11 (package): 62168058502
spl id: c965a846-a59d-44b6-8091-f1c426e07cc6
spl set id: b1077b76-7ae7-4b1b-a972-c1b10e9671f9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.